Business Wire | Oct 14, 2021 05:55AM EDT

UnitedHealth Group Reports Third Quarter 2021 Performance

Oct. 14, 2021

MINNETONKA, Minn.--(BUSINESS WIRE)--Oct. 14, 2021--Consistent, well-balanced growth continued across UnitedHealth Group (NYSE: UNH) in the third quarter 2021.

"Our positive growth and operating results are thanks to the 340,000 Optum and UnitedHealthcare team members who strive every day to help clinicians deliver and people access quality, affordable health care," said Andrew Witty, chief executive officer of UnitedHealth Group.

The Company increased its full year net earnings outlook to $17.70 to $17.95 per share and adjusted earnings to $18.65 to $18.90 per share. The Company's full year 2021 outlook for net unfavorable COVID-19 earnings effects is consistent with previous expectations.

Quarterly Financial Performance

Three Months Ended

September 30, September 30, June 30, 2021 2020 2021

Revenues $72.3 billion $65.1 billion $71.3 billion

Earnings from Operations $5.7 billion $4.7 billion $6.0 billion

Net Margin 5.6% 4.9% 6.0%

* UnitedHealth Group's third quarter 2021 revenues of $72.3 billion grew $7.2 billion or 11.1% year-over-year, reflecting balanced, double-digit growth at both Optum and UnitedHealthcare.

* Third quarter 2021 earnings from operations were $5.7 billion including well diversified contributions from across the enterprise. The Optum businesses comprised 54% of the consolidated total. Adjusted net earnings per share were $4.52.

* Cash flows from operations in the third quarter were $7.6 billion or 1.8 times net income and $19.1 billion year-to-date or 1.4 times net income.

* The third quarter 2021 medical care ratio of 83.0% compared to 81.9% last year, with the variance due largely to the repeal of the health insurance tax. Favorable medical reserve development was $700 million, with $520 million related to 2021 and a majority of the effect offset by rebates, risk-corridors and other related factors. Days claims payable of 50.4 days compared to 49.1 days in the second quarter 2021 and 46.8 days in the third quarter 2020.

* The operating cost ratio of 14.8% this quarter decreased from 15.6% in third quarter 2020 primarily due to the repeal of the health insurance tax and continued productivity advances, partially offset by business mix and growth and innovation investments.

* The Company returned $1.4 billion to shareholders in the third quarter via dividends, an increase of 16% in the annual dividend rate from the year ago quarter. The Company repurchased 2.5 million shares for $1.1 billion in the quarter.

* Return on equity of 23.5% in the quarter reflected the Company's strong overall operating performance and efficient capital structure.

UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by reducing the total cost of care, enhancing the quality of care received, improving health and wellness and simplifying the health care experience.

Quarterly Financial Performance

Three Months Ended

September 30, September 30, June 30, 2021 2020 2021

Revenues $55.9 billion $50.4 billion $55.5 billion

Earnings from Operations $2.7 billion $2.1 billion $3.1 billion

Operating Margin 4.7% 4.1% 5.6%

* UnitedHealthcare third quarter 2021 revenues of $55.9 billion grew by $5.6 billion or 11.0% compared to the previous year. Continued strong growth in UnitedHealthcare's community and senior offerings and growth serving 320,000 more people in commercial risk and self-funded offerings this quarter contributed to the revenue expansion. This includes commercial business expansion and organic growth in both specialty and medical benefits, such as innovative, consumer-centric and provider-led benefit plans.

* Total people served by UnitedHealthcare grew by 790,000 in the third quarter and nearly 2 million people since the end of 2020, led by continued strong growth in Medicare Advantage, Dual Special Needs Plans and Medicaid more broadly. New Medicaid regions served this year include North Carolina, Kentucky and Indiana, with recent new contract awards in Nevada, Ohio and Hawaii. UnitedHealthcare is on pace to grow by more than 900,000 additional people in Medicare Advantage this year including Dual Special Needs Plans.

* Third quarter 2021 operating earnings were $2.7 billion compared to $2.1 billion last year, reflecting strong member growth, reduced net COVID-19 effects and a continued focus on operating cost management.

Optum is a health services business serving the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, data analytics, technology and clinical insights, Optum helps improve overall health system performance: optimizing care quality, reducing health care costs and improving the consumer experience.

Quarterly Financial Performance

Three Months Ended

September 30, September 30, June 30, 2021 2020 2021

Revenues $39.8 billion $34.9 billion $38.3 billion

Earnings from Operations $3.1 billion $2.6 billion $2.9 billion

Operating Margin 7.7% 7.4% 7.5%

* Optum third quarter revenues of $39.8 billion grew 13.9% and operating earnings of $3.1 billion grew 18.5% compared to the prior year, with each of the three Optum businesses contributing to operating earnings growth, led by OptumHealth.

* OptumHealth revenue per consumer served grew 30% year-over-year in the quarter and the business grew to serve 99 million people at the end of third quarter 2021 compared to 98 million a year ago. This growth included more people served in value-based care arrangements and further build-out of local market care delivery services, including clinic-based and outpatient services, and in-home physical and digital capabilities.

* OptumInsight's revenue backlog of $22.3 billion increased $2.4 billion or 12% compared to the third quarter 2020, with the growing backlog and pipeline driven by comprehensive managed services, including revenue management, care coordination, digital modernization and payment integrity services. Recent business wins include a significant new client relationship with SSM Health to help accelerate operational performance, clinical outcomes and patient health care experiences.

* OptumRx adjusted scripts in the quarter were 344 million, growth of 6% compared to last year driven by growth in people served and as the provision of care and usage of pharmaceuticals has continued to recover over the last year. OptumRx continues to grow and diversify its pharmacy care offerings, including the number of community-based behavioral health pharmacies and growth in specialty pharmacy, infusion services and e-commerce offerings.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: Optum, which provides information and technology-enabled health services; and UnitedHealthcare, which provides health care coverage and benefits services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Earnings Conference Call

As previously announced, UnitedHealth Group will discuss the company's results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be available on the same site through October 28, 2021. The conference call replay can also be accessed by dialing 1-888-203-1112, Conference Code: 5065077. This earnings release and the Form 8-K dated October 14, 2021 can also be accessed from the Investor Relations page of the Company's website.

Non-GAAP Financial Information

This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Forward-Looking Statements

The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities law. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; the DOJ's legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; risks and uncertainties associated with the pharmacy benefits management industry; competitive pressures; changes in or challenges to our public sector contract awards; our ability to contract on competitive terms with physicians, hospitals and other service providers; failure to attract, develop, retain, and manage the succession of key employees and

executives; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations); failure to achieve targeted operating cost productivity improvements; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

UNITEDHEALTH GROUPEarnings Release Schedules and Supplementary InformationQuarter Ended September 30, 2021- Condensed Consolidated Statements of Operations- Condensed Consolidated Balance Sheets- Condensed Consolidated Statements of Cash Flows- Supplemental Financial Information - Businesses- Supplemental Financial Information - Business Metrics- Reconciliation of Non-GAAP Financial Measure

UNITEDHEALTH GROUPCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in millions, except per share data)(unaudited)Three Months Ended September 30,

Nine Months Ended September 30,

2021

2020

2021

2020

RevenuesPremiums$56,967

$50,863

$168,686

$150,897

Products8,703

8,777

25,476

25,455

Services6,164

5,124

18,181

14,265

Investment and other income503

351

1,511

1,057

Total revenues72,337

65,115

213,854

191,674

Operating costsMedical costs47,302

41,636

138,752

117,314

Operating costs10,725

10,174

31,307

30,190

Cost of products sold7,802

7,935

23,034

23,123

Depreciation and amortization796

719

2,332

2,159

Total operating costs66,625

60,464

195,425

172,786

Earnings from operations5,712

4,651

18,429

18,888

Interest expense(422)

(395)

(1,229)

(1,262)

Earnings before income taxes5,290

4,256

17,200

17,626

Provision for income taxes(1,099)

(1,000)

(3,659)

(4,209)

Net earnings4,191

3,256

13,541

13,417

Earnings attributable to noncontrolling interests(105)

(84)

(327)

(226)

Net earnings attributable to UnitedHealth Group common shareholders$4,086

$3,172

$13,214

$13,191

Diluted earnings per share attributable to UnitedHealth Group common shareholders$4.28

$3.30

$13.82

$13.73

Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)$4.52

$3.51

$14.54

$14.36

Diluted weighted-average common shares outstanding955

962

956

961

(a) See page 6 for a reconciliation of the non-GAAP measure

UNITEDHEALTH GROUPCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(in millions, except per share data)(unaudited) Three Months Nine Months Ended Ended September 30, September 30,

2021 2020 2021 2020

RevenuesPremiums $56,967 $50,863 $168,686 $150,897

Products 8,703 8,777 25,476 25,455

Services 6,164 5,124 18,181 14,265

Investment and other income 503 351 1,511 1,057

Total revenues 72,337 65,115 213,854 191,674

Operating costsMedical costs 47,302 41,636 138,752 117,314

Operating costs 10,725 10,174 31,307 30,190

Cost of products sold 7,802 7,935 23,034 23,123

Depreciation and amortization 796 719 2,332 2,159

Total operating costs 66,625 60,464 195,425 172,786

Earnings from operations 5,712 4,651 18,429 18,888

Interest expense (422) (395) (1,229) (1,262)

Earnings before income taxes 5,290 4,256 17,200 17,626

Provision for income taxes (1,099) (1,000) (3,659) (4,209)

Net earnings 4,191 3,256 13,541 13,417

Earnings attributable to (105) (84) (327) (226)noncontrolling interestsNet earnings attributable to $4,086 $3,172 $13,214 $13,191UnitedHealth Group common shareholdersDiluted earnings per share $4.28 $3.30 $13.82 $13.73attributable to UnitedHealth Groupcommon shareholdersAdjusted earnings per share $4.52 $3.51 $14.54 $14.36attributable to UnitedHealth Groupcommon shareholders (a)Diluted weighted-average common shares 955 962 956 961outstanding (a) See page 6 for a reconciliation of the non-GAAP measure

UNITEDHEALTH GROUPCONDENSED CONSOLIDATED BALANCE SHEETS(in millions)(unaudited)September 30,

December 31,

2021

2020

AssetsCash and short-term investments$23,871

$19,781

Accounts receivable, net14,152

12,870

Other current assets23,587

21,067

Total current assets61,610

53,718

Long-term investments44,777

41,242

Other long-term assets106,658

102,329

Total assets$213,045

$197,289

Liabilities, redeemable noncontrolling interests and equityMedical costs payable$25,918

$21,872

Short-term borrowings and current maturities of long-term debt3,620

4,819

Other current liabilities50,037

45,729

Total current liabilities79,575

72,420

Long-term debt, less current maturities43,345

38,648

Other long-term liabilities15,493

15,682

Redeemable noncontrolling interests1,373

2,211

Equity73,259

68,328

Total liabilities, redeemable noncontrolling interests and equity$213,045

$197,289

UNITEDHEALTH GROUPCONDENSED CONSOLIDATED BALANCE SHEETS(in millions)(unaudited) September December 30, 31,

2021 2020

AssetsCash and short-term investments $23,871 $19,781

Accounts receivable, net 14,152 12,870

Other current assets 23,587 21,067

Total current assets 61,610 53,718

Long-term investments 44,777 41,242

Other long-term assets 106,658 102,329

Total assets $213,045 $197,289

Liabilities, redeemable noncontrolling interests andequityMedical costs payable $25,918 $21,872

Short-term borrowings and current maturities of 3,620 4,819long-term debtOther current liabilities 50,037 45,729

Total current liabilities 79,575 72,420

Long-term debt, less current maturities 43,345 38,648

Other long-term liabilities 15,493 15,682

Redeemable noncontrolling interests 1,373 2,211

Equity 73,259 68,328

Total liabilities, redeemable noncontrolling interests $213,045 $197,289and equityUNITEDHEALTH GROUPCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in millions)(unaudited)Nine Months Ended September 30,

2021

2020

Operating ActivitiesNet earnings$13,541

$13,417

Noncash items:Depreciation and amortization2,332

2,159

Deferred income taxes and other178

167

Share-based compensation591

527

Net changes in operating assets and liabilities2,483

(197)

Cash flows from operating activities19,125

16,073

Investing ActivitiesPurchases of investments, net of sales and maturities(3,702)

(1,386)

Purchases of property, equipment and capitalized software(1,759)

(1,477)

Cash paid for acquisitions, net(4,727)

(4,326)

Other, net(900)

(165)

Cash flows used for investing activities(11,088)

(7,354)

Financing ActivitiesCommon share repurchases(3,950)

(2,541)

Dividends paid(3,915)

(3,400)

Net change in short-term borrowings and long-term debt3,733

2,941

Other, net304

1,006

Cash flows used for financing activities(3,828)

(1,994)

Effect of exchange rate changes on cash and cash equivalents(45)

(160)

Increase in cash and cash equivalents4,164

6,565

Cash and cash equivalents, beginning of period16,921

10,985

Cash and cash equivalents, end of period$21,085

$17,550

UNITEDHEALTH GROUPCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in millions)(unaudited) Nine Months Ended September 30,

2021 2020

Operating ActivitiesNet earnings $13,541 $13,417

Noncash items:Depreciation and amortization 2,332 2,159

Deferred income taxes and other 178 167

Share-based compensation 591 527

Net changes in operating assets and liabilities 2,483 (197)

Cash flows from operating activities 19,125 16,073

Investing ActivitiesPurchases of investments, net of sales and maturities (3,702) (1,386)

Purchases of property, equipment and capitalized software (1,759) (1,477)

Cash paid for acquisitions, net (4,727) (4,326)

Other, net (900) (165)

Cash flows used for investing activities (11,088) (7,354)

Financing ActivitiesCommon share repurchases (3,950) (2,541)

Dividends paid (3,915) (3,400)

Net change in short-term borrowings and long-term debt 3,733 2,941

Other, net 304 1,006

Cash flows used for financing activities (3,828) (1,994)

Effect of exchange rate changes on cash and cash equivalents (45) (160)

Increase in cash and cash equivalents 4,164 6,565

Cash and cash equivalents, beginning of period 16,921 10,985

Cash and cash equivalents, end of period $21,085 $17,550

UNITEDHEALTH GROUPSUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES(in millions, except percentages)(unaudited)Three Months Ended September 30,

Nine Months Ended September 30,

2021

2020

2021

2020

RevenuesUnitedHealthcare$55,927

$50,373

$166,515

$150,548

Optum39,785

34,923

114,472

100,457

Eliminations(23,375)

(20,181)

(67,133)

(59,331)

Total consolidated revenues$72,337

$65,115

$213,854

$191,674

Earnings from OperationsUnitedHealthcare$2,651

$2,068

$9,854

$11,963

Optum (a)3,061

2,583

8,575

6,925

Total consolidated earnings from operations$5,712

$4,651

$18,429

$18,888

Operating MarginUnitedHealthcare4.7%

4.1%

5.9%

7.9%

Optum7.7%

7.4%

7.5%

6.9%

Consolidated operating margin7.9%

7.1%

8.6%

9.9%

RevenuesUnitedHealthcare Employer & Individual$15,094

$14,081

$44,668

$41,324

UnitedHealthcare Medicare & Retirement24,931

22,606

75,709

68,613

UnitedHealthcare Community & State13,763

11,820

39,846

34,796

UnitedHealthcare Global2,139

1,866

6,292

5,815

OptumHealth$13,812

$10,499

$39,515

$28,830

OptumInsight3,139

2,767

8,948

7,893

OptumRx23,337

22,081

67,465

65,009

Optum eliminations(503)

(424)

(1,456)

(1,275)

UNITEDHEALTH GROUPSUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES(in millions, except percentages)(unaudited) Three Months Ended Nine Months Ended September 30, September 30,

2021 2020 2021 2020

RevenuesUnitedHealthcare $55,927 $50,373 $166,515 $150,548

Optum 39,785 34,923 114,472 100,457

Eliminations (23,375) (20,181) (67,133) (59,331)

Total consolidated revenues $72,337 $65,115 $213,854 $191,674

Earnings from OperationsUnitedHealthcare $2,651 $2,068 $9,854 $11,963

Optum (a) 3,061 2,583 8,575 6,925

Total consolidated earnings from $5,712 $4,651 $18,429 $18,888operationsOperating MarginUnitedHealthcare 4.7% 4.1% 5.9% 7.9%

Optum 7.7% 7.4% 7.5% 6.9%

Consolidated operating margin 7.9% 7.1% 8.6% 9.9%

RevenuesUnitedHealthcare Employer & $15,094 $14,081 $44,668 $41,324IndividualUnitedHealthcare Medicare & 24,931 22,606 75,709 68,613RetirementUnitedHealthcare Community & State 13,763 11,820 39,846 34,796

UnitedHealthcare Global 2,139 1,866 6,292 5,815

OptumHealth $13,812 $10,499 $39,515 $28,830

OptumInsight 3,139 2,767 8,948 7,893

OptumRx 23,337 22,081 67,465 65,009

Optum eliminations (503) (424) (1,456) (1,275)

(a)Earnings from operations for Optum for the three and nine months ended September 30, 2021 included $1,143 and $3,233 for OptumHealth; $906 and $2,447 for OptumInsight; and $1,012 and $2,895 for OptumRx, respectively. Earnings from operations for Optum for the three and nine months ended September 30, 2020 included $835 and $2,388 for OptumHealth; $785 and $1,882 for OptumInsight; and $963 and $2,655 for OptumRx, respectively. Earnings from operations for Optum for the three and nine months ended September 30, 2021 included $1,143 and $3,233 for OptumHealth; $906 and(a) $2,447 for OptumInsight; and $1,012 and $2,895 for OptumRx, respectively. Earnings from operations for Optum for the three and nine months ended September 30, 2020 included $835 and $2,388 for OptumHealth; $785 and $1,882 for OptumInsight; and $963 and $2,655 for OptumRx, respectively.UNITEDHEALTH GROUPSUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICSUNITEDHEALTHCARE CUSTOMER PROFILE(in thousands)People ServedSeptember 30, 2021

June 30, 2021

December 31, 2020

September 30, 2020

Commercial:Risk-based7,960

7,840

7,910

7,950

Fee-based18,595

18,395

18,310

18,400

Total Commercial26,555

26,235

26,220

26,350

Medicare Advantage6,455

6,385

5,710

5,670

Medicaid7,510

7,130

6,620

6,435

Medicare Supplement (Standardized)4,405

4,390

4,460

4,450

Total Community and Senior18,370

17,905

16,790

16,555

Total UnitedHealthcare - Domestic Medical44,925

44,140

43,010

42,905

Global5,490

5,485

5,425

5,285

Total UnitedHealthcare - Medical50,415

49,625

48,435

48,190

Supplemental DataMedicare Part D stand-alone3,725

3,750

4,045

4,075

OPTUM PERFORMANCE METRICSSeptember 30, 2021

June 30, 2021

December 31, 2020

September 30, 2020

OptumHealth Consumers Served (in millions)99

99

98

98

OptumInsight Contract Backlog (in billions)$22.3

$21.3

$20.2

$19.9

OptumRx Quarterly Adjusted Scripts (in millions)344

342

331

325

Note: UnitedHealth Group served 146 million unique individuals across all businesses at September 30, 2021.UNITEDHEALTH GROUPSUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS UNITEDHEALTHCARE CUSTOMER PROFILE(in thousands) September June 30, December SeptemberPeople Served 30, 2021 2021 31, 2020 30, 2020

Commercial:Risk-based 7,960 7,840 7,910 7,950

Fee-based 18,595 18,395 18,310 18,400

Total Commercial 26,555 26,235 26,220 26,350

Medicare Advantage 6,455 6,385 5,710 5,670

Medicaid 7,510 7,130 6,620 6,435

Medicare Supplement 4,405 4,390 4,460 4,450(Standardized)Total Community and Senior 18,370 17,905 16,790 16,555

Total UnitedHealthcare - 44,925 44,140 43,010 42,905Domestic MedicalGlobal 5,490 5,485 5,425 5,285

Total UnitedHealthcare - 50,415 49,625 48,435 48,190Medical Supplemental DataMedicare Part D stand-alone 3,725 3,750 4,045 4,075

OPTUM PERFORMANCE METRICS September June 30, December September 30, 2021 2021 31, 2020 30, 2020

OptumHealth Consumers Served 99 99 98 98(in millions)OptumInsight Contract Backlog $22.3 $21.3 $20.2 $19.9(in billions)OptumRx Quarterly Adjusted 344 342 331 325Scripts (in millions) Note: UnitedHealth Group served 146 million unique individuals across allbusinesses at September 30, 2021.UNITEDHEALTH GROUPRECONCILIATION OF NON-GAAP FINANCIAL MEASURE(in millions, except per share data)(unaudited)ADJUSTED NET EARNINGS PER SHARE(a)Three Months Ended September 30,

Nine Months Ended September 30,

Projected Year Ended December 31,

2021

2020

2021

2020

2021

GAAP net earnings attributable to UnitedHealth Group common shareholders$4,086

$3,172

$13,214

$13,191

$16,900 - $17,150Intangible amortization305

269

904

801

~1,200Tax effect of intangible amortization(74)

(64)

(220)

(194)

~(290)Adjusted net earnings attributable to UnitedHealth Group common shareholders$4,317

$3,377

$13,898

$13,798

$17,800 - $18,050GAAP diluted earnings per share$4.28

$3.30

$13.82

$13.73

$17.70 - $17.95Intangible amortization per share0.32

0.28

0.95

0.83

~1.25Tax effect per share of intangible amortization(0.08)

(0.07)

(0.23)

(0.20)

~(0.30)Adjusted diluted earnings per share$4.52

$3.51

$14.54

$14.36

$18.65 - $18.90UNITEDHEALTH GROUPRECONCILIATION OF NON-GAAP FINANCIAL MEASURE(in millions, except per share data)(unaudited) ADJUSTED NET EARNINGS PER SHARE^(a) Projected Three Months Nine Months Ended Year Ended September 30, Ended September 30, December 31,

2021 2020 2021 2020 2021

GAAP net earnings attributable $4,086 $3,172 $13,214 $13,191 $16,900 -to UnitedHealth Group common $17,150shareholdersIntangible amortization 305 269 904 801 ~1,200

Tax effect of intangible (74) (64) (220) (194) ~(290)amortizationAdjusted net earnings $4,317 $3,377 $13,898 $13,798 $17,800 -attributable to UnitedHealth $18,050Group common shareholders GAAP diluted earnings per $4.28 $3.30 $13.82 $13.73 $17.70 -share $17.95Intangible amortization per 0.32 0.28 0.95 0.83 ~1.25shareTax effect per share of (0.08) (0.07) (0.23) (0.20) ~(0.30)intangible amortizationAdjusted diluted earnings per $4.52 $3.51 $14.54 $14.36 $18.65 -share $18.90(a)Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company's acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company's revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share. View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005338/en/

CONTACT: Investors: Brett Manderfeld Senior Vice President 952-936-7216

CONTACT: Media: Matt Stearns Senior Vice President 202-276-0085